| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 1.66e-07 | 10 | 108 | 4 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 1.66e-07 | 10 | 108 | 4 | GO:0005391 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ACSL6 DYNC2H1 DHX40 ACSF2 DMC1 CCT8L2 ABCA5 DDX25 ATP1A1 ATP1A2 ATP1A3 CCT8L1P ATP1A4 DNAH5 ATP2B1 SLC27A3 | 1.95e-07 | 614 | 108 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 2.59e-07 | 11 | 108 | 4 | GO:0008556 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.39e-06 | 36 | 108 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.39e-06 | 36 | 108 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 5.30e-06 | 7 | 108 | 3 | GO:1990239 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.14e-05 | 62 | 108 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DYNC2H1 DHX40 DMC1 ABCA5 DDX25 ATP1A1 ATP1A2 ATP1A3 ATP1A4 DNAH5 ATP2B1 | 2.71e-05 | 441 | 108 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.81e-05 | 109 | 108 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 6.68e-05 | 15 | 108 | 3 | GO:0004467 | |
| GeneOntologyMolecularFunction | ankyrin binding | 2.52e-04 | 23 | 108 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DYNC2H1 DHX40 ATL3 DNAJC27 DMC1 ABCA5 DDX25 ATP1A1 ATP1A2 ATP1A3 ATP1A4 DNAH5 ATP2B1 | 2.82e-04 | 775 | 108 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.96e-04 | 167 | 108 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 3.65e-04 | 26 | 108 | 3 | GO:0015645 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 4.09e-04 | 27 | 108 | 3 | GO:0016405 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 4.16e-04 | 178 | 108 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DYNC2H1 DHX40 ATL3 DNAJC27 DMC1 ABCA5 DDX25 ATP1A1 ATP1A2 ATP1A3 ATP1A4 DNAH5 ATP2B1 | 5.99e-04 | 839 | 108 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DYNC2H1 DHX40 ATL3 DNAJC27 DMC1 ABCA5 DDX25 ATP1A1 ATP1A2 ATP1A3 ATP1A4 DNAH5 ATP2B1 | 6.06e-04 | 840 | 108 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DYNC2H1 DHX40 ATL3 DNAJC27 DMC1 ABCA5 DDX25 ATP1A1 ATP1A2 ATP1A3 ATP1A4 DNAH5 ATP2B1 | 6.06e-04 | 840 | 108 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 6.19e-04 | 31 | 108 | 3 | GO:0016878 | |
| GeneOntologyMolecularFunction | thyroid hormone transmembrane transporter activity | 1.02e-03 | 9 | 108 | 2 | GO:0015349 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A5 SLCO1C1 ABCA5 ATP1A1 ATP1A2 ATP1A3 ATP1A4 ATP2B1 SLC16A10 | 1.14e-03 | 477 | 108 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 1.41e-03 | 41 | 108 | 3 | GO:0016877 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 1.54e-03 | 11 | 108 | 2 | GO:0047676 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 1.83e-03 | 161 | 108 | 5 | GO:0051087 | |
| GeneOntologyMolecularFunction | aromatic amino acid transmembrane transporter activity | 2.17e-03 | 13 | 108 | 2 | GO:0015173 | |
| GeneOntologyMolecularFunction | potassium ion binding | 2.53e-03 | 14 | 108 | 2 | GO:0030955 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.53e-03 | 14 | 108 | 2 | GO:0031402 | |
| GeneOntologyBiologicalProcess | response to glycoside | 3.28e-09 | 5 | 106 | 4 | GO:1903416 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 2.11e-07 | 11 | 106 | 4 | GO:0010248 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 1.25e-06 | 37 | 106 | 5 | GO:0055075 | |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 1.49e-06 | 17 | 106 | 4 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 1.49e-06 | 17 | 106 | 4 | GO:0036376 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.93e-06 | 230 | 106 | 9 | GO:0098739 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 6.34e-06 | 51 | 106 | 5 | GO:1990573 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ACSL6 GRM1 ACE2 SLC7A1 NF1 SLCO1C1 PRKG1 ATP1A2 ATP1A3 SLC27A3 SLC16A10 | 8.57e-06 | 410 | 106 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | ACSL6 GRM1 ACE2 SLC7A1 NF1 SLCO1C1 PRKG1 ATP1A2 ATP1A3 SLC27A3 SLC16A10 | 8.97e-06 | 412 | 106 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 1.63e-05 | 30 | 106 | 4 | GO:0006883 | |
| GeneOntologyBiologicalProcess | head development | SALL3 RARG NRCAM DYNC2H1 ZEB2 METTL14 NCOR2 NF1 CELF1 PSMG1 UGP2 PRKG1 ATP1A2 ATP1A3 DNAH5 HYDIN | 1.81e-05 | 919 | 106 | 16 | GO:0060322 |
| GeneOntologyBiologicalProcess | L-amino acid transport | 2.00e-05 | 108 | 106 | 6 | GO:0015807 | |
| GeneOntologyBiologicalProcess | brain development | SALL3 NRCAM DYNC2H1 ZEB2 METTL14 NCOR2 NF1 CELF1 PSMG1 UGP2 PRKG1 ATP1A2 ATP1A3 DNAH5 HYDIN | 3.29e-05 | 859 | 106 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | aromatic amino acid transport | 3.63e-05 | 13 | 106 | 3 | GO:0015801 | |
| GeneOntologyBiologicalProcess | forebrain development | SALL3 DYNC2H1 ZEB2 METTL14 NCOR2 NF1 CELF1 PRKG1 ATP1A2 ATP1A3 DNAH5 | 4.35e-05 | 489 | 106 | 11 | GO:0030900 |
| GeneOntologyBiologicalProcess | spermatid development | 6.28e-05 | 262 | 106 | 8 | GO:0007286 | |
| GeneOntologyBiologicalProcess | amino acid transport | 6.71e-05 | 195 | 106 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | organic anion transport | ACSL6 GRM1 ACE2 SLC7A1 NF1 SLCO1C1 PRKG1 ATP1A2 ATP1A3 SLC27A3 SLC16A10 | 6.93e-05 | 515 | 106 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | spermatid differentiation | 8.16e-05 | 272 | 106 | 8 | GO:0048515 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 1.07e-04 | 91 | 106 | 5 | GO:0140115 | |
| GeneOntologyBiologicalProcess | spermatogenesis | METTL14 CFAP65 DMC1 GMCL1 GMCL2 CELF1 SPATA16 DDX25 DLEC1 PRKG1 ATP1A4 DPY19L2P2 KNL1 | 1.14e-04 | 744 | 106 | 13 | GO:0007283 |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 1.37e-04 | 51 | 106 | 4 | GO:0055078 | |
| GeneOntologyBiologicalProcess | male gamete generation | METTL14 CFAP65 DMC1 GMCL1 GMCL2 CELF1 SPATA16 DDX25 DLEC1 PRKG1 ATP1A4 DPY19L2P2 KNL1 | 1.45e-04 | 762 | 106 | 13 | GO:0048232 |
| GeneOntologyBiologicalProcess | response to potassium ion | 1.64e-04 | 21 | 106 | 3 | GO:0035864 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 1.67e-04 | 100 | 106 | 5 | GO:0061337 | |
| GeneOntologyBiologicalProcess | germ cell development | CFAP65 DMC1 GMCL1 GMCL2 CELF1 SPATA16 DDX25 PRKG1 DPY19L2P2 KNL1 | 1.90e-04 | 482 | 106 | 10 | GO:0007281 |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 2.26e-04 | 58 | 106 | 4 | GO:0089718 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 3.15e-04 | 26 | 106 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | telencephalon development | 3.18e-04 | 332 | 106 | 8 | GO:0021537 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | CFAP65 DMC1 GMCL1 GMCL2 CELF1 SPATA16 DDX25 PRKG1 DPY19L2P2 KNL1 | 3.87e-04 | 527 | 106 | 10 | GO:0022412 |
| GeneOntologyBiologicalProcess | amygdala development | 3.87e-04 | 6 | 106 | 2 | GO:0021764 | |
| GeneOntologyBiologicalProcess | regulation of mast cell apoptotic process | 3.87e-04 | 6 | 106 | 2 | GO:0033025 | |
| GeneOntologyBiologicalProcess | mast cell apoptotic process | 3.87e-04 | 6 | 106 | 2 | GO:0033024 | |
| GeneOntologyBiologicalProcess | tryptophan transport | 3.87e-04 | 6 | 106 | 2 | GO:0015827 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 3.89e-04 | 120 | 106 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 4.03e-04 | 344 | 106 | 8 | GO:0003018 | |
| GeneOntologyBiologicalProcess | mast cell homeostasis | 5.40e-04 | 7 | 106 | 2 | GO:0033023 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 3.23e-07 | 12 | 108 | 4 | GO:0005890 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 1.19e-04 | 49 | 108 | 4 | GO:0090533 | |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 1.58e-04 | 4 | 108 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 1.88e-04 | 55 | 108 | 4 | GO:0098533 | |
| Domain | P-type_ATPase_IIC | 1.30e-08 | 6 | 103 | 4 | IPR005775 | |
| Domain | - | 1.93e-08 | 16 | 103 | 5 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 1.93e-08 | 16 | 103 | 5 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.72e-08 | 17 | 103 | 5 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.72e-08 | 17 | 103 | 5 | PF00689 | |
| Domain | Cation_ATPase_N | 3.74e-08 | 18 | 103 | 5 | PF00690 | |
| Domain | Cation_ATPase_N | 3.74e-08 | 18 | 103 | 5 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.06e-08 | 19 | 103 | 5 | IPR004014 | |
| Domain | HAD-like_dom | 2.64e-07 | 79 | 103 | 7 | IPR023214 | |
| Domain | - | 8.27e-07 | 32 | 103 | 5 | 3.40.1110.10 | |
| Domain | - | 8.27e-07 | 32 | 103 | 5 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.32e-06 | 35 | 103 | 5 | IPR023299 | |
| Domain | P_typ_ATPase | 1.52e-06 | 36 | 103 | 5 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 1.52e-06 | 36 | 103 | 5 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 1.52e-06 | 36 | 103 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.75e-06 | 37 | 103 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.75e-06 | 37 | 103 | 5 | PF00122 | |
| Domain | EYA_fam | 1.79e-04 | 4 | 103 | 2 | IPR028472 | |
| Domain | EYA_dom | 1.79e-04 | 4 | 103 | 2 | IPR006545 | |
| Domain | AMP-binding_CS | 3.86e-04 | 26 | 103 | 3 | IPR020845 | |
| Domain | AMP_BINDING | 4.83e-04 | 28 | 103 | 3 | PS00455 | |
| Domain | AMP-binding | 5.93e-04 | 30 | 103 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 5.93e-04 | 30 | 103 | 3 | IPR000873 | |
| Domain | DHC_N1 | 8.25e-04 | 8 | 103 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 8.25e-04 | 8 | 103 | 2 | IPR013594 | |
| Domain | PapD-like | 1.06e-03 | 9 | 103 | 2 | IPR008962 | |
| Domain | Peptidase_M12B_N | 1.29e-03 | 39 | 103 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.29e-03 | 39 | 103 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.39e-03 | 40 | 103 | 3 | PS00427 | |
| Domain | Reprolysin | 1.39e-03 | 40 | 103 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 1.39e-03 | 40 | 103 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.39e-03 | 40 | 103 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 1.39e-03 | 40 | 103 | 3 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 1.49e-03 | 41 | 103 | 3 | PS00546 | |
| Domain | Disintegrin_dom | 1.49e-03 | 41 | 103 | 3 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 1.71e-03 | 43 | 103 | 3 | IPR001818 | |
| Domain | TIL | 1.92e-03 | 12 | 103 | 2 | PF01826 | |
| Domain | C8 | 1.92e-03 | 12 | 103 | 2 | PF08742 | |
| Domain | ZINC_PROTEASE | 2.12e-03 | 98 | 103 | 4 | PS00142 | |
| Domain | Unchr_dom_Cys-rich | 2.26e-03 | 13 | 103 | 2 | IPR014853 | |
| Domain | C8 | 2.26e-03 | 13 | 103 | 2 | SM00832 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.62e-03 | 14 | 103 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.62e-03 | 14 | 103 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.62e-03 | 14 | 103 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.62e-03 | 14 | 103 | 2 | PF08393 | |
| Domain | MT | 2.62e-03 | 14 | 103 | 2 | PF12777 | |
| Domain | AAA_8 | 2.62e-03 | 14 | 103 | 2 | PF12780 | |
| Domain | TIL_dom | 2.62e-03 | 14 | 103 | 2 | IPR002919 | |
| Domain | ATPase_dyneun-rel_AAA | 2.62e-03 | 14 | 103 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.62e-03 | 14 | 103 | 2 | PF07728 | |
| Domain | - | DYNC2H1 DHX40 ATL3 DNAJC27 LRRK1 DMC1 CHST15 ABCA5 DDX25 DNAH5 HYDIN | 2.71e-03 | 746 | 103 | 11 | 3.40.50.300 |
| Domain | DHC_fam | 3.02e-03 | 15 | 103 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.02e-03 | 15 | 103 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.02e-03 | 15 | 103 | 2 | PF03028 | |
| Domain | VWD | 3.44e-03 | 16 | 103 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.44e-03 | 16 | 103 | 2 | IPR001846 | |
| Domain | VWFD | 3.44e-03 | 16 | 103 | 2 | PS51233 | |
| Domain | VWD | 3.44e-03 | 16 | 103 | 2 | PF00094 | |
| Domain | - | SEMA3C MYLK NRCAM HLA-B OBSCN F13A1 IGSF10 NFKB1 IGSF1 USH2A | 3.61e-03 | 663 | 103 | 10 | 2.60.40.10 |
| Domain | AMP-bd_C | 3.88e-03 | 17 | 103 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 3.88e-03 | 17 | 103 | 2 | PF13193 | |
| Domain | Ig_I-set | 4.05e-03 | 190 | 103 | 5 | IPR013098 | |
| Domain | I-set | 4.05e-03 | 190 | 103 | 5 | PF07679 | |
| Domain | CTCK_1 | 4.35e-03 | 18 | 103 | 2 | PS01185 | |
| Domain | VWC_out | 4.84e-03 | 19 | 103 | 2 | SM00215 | |
| Domain | TSP_1 | 5.09e-03 | 63 | 103 | 3 | PF00090 | |
| Pathway | KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION | 7.46e-06 | 23 | 79 | 4 | M4361 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.24e-05 | 54 | 79 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.24e-05 | 54 | 79 | 5 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.36e-05 | 55 | 79 | 5 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.62e-05 | 57 | 79 | 5 | MM15643 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 8.70e-05 | 42 | 79 | 4 | M16473 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.77e-04 | 103 | 79 | 5 | MM15196 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.22e-04 | 165 | 79 | 6 | MM15026 | |
| Pubmed | 9.13e-11 | 4 | 109 | 4 | 21849490 | ||
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 4.55e-10 | 5 | 109 | 4 | 3035563 | |
| Pubmed | 1.36e-09 | 6 | 109 | 4 | 3036582 | ||
| Pubmed | Differential involvement of Na(+),K(+)-ATPase isozymes in preimplantation development of the mouse. | 3.17e-09 | 7 | 109 | 4 | 10837135 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 2158121 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 2822726 | ||
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 2.99e-08 | 3 | 109 | 3 | 26373354 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 17947306 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 28465228 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 18044013 | ||
| Pubmed | Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes. | 2.99e-08 | 3 | 109 | 3 | 30819023 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 19058785 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 8203495 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 26911348 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 25994790 | ||
| Pubmed | 3.08e-08 | 29 | 109 | 5 | 15071553 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 21731499 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 12458206 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 26147384 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 17446412 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 19751721 | ||
| Pubmed | Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. | 1.20e-07 | 4 | 109 | 3 | 19376779 | |
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 17234593 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 2887455 | ||
| Pubmed | Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. | 5.95e-07 | 6 | 109 | 3 | 10636900 | |
| Pubmed | Expression and distribution of Na, K-ATPase isoforms in the human uterus. | 1.04e-06 | 7 | 109 | 3 | 20065300 | |
| Pubmed | 1.66e-06 | 8 | 109 | 3 | 19683723 | ||
| Pubmed | 1.66e-06 | 8 | 109 | 3 | 2885848 | ||
| Pubmed | 1.66e-06 | 8 | 109 | 3 | 23652595 | ||
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 15253893 | ||
| Pubmed | Retinal pigment epithelial integrity is compromised in the developing albino mouse retina. | 6.45e-06 | 12 | 109 | 3 | 27097562 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15781423 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17999917 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15564586 | ||
| Pubmed | Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. | 9.73e-06 | 2 | 109 | 2 | 20669279 | |
| Pubmed | Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. | 9.73e-06 | 2 | 109 | 2 | 23184150 | |
| Pubmed | Mouse germ cell-less as an essential component for nuclear integrity. | 9.73e-06 | 2 | 109 | 2 | 12556490 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 6324196 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 27999401 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18490652 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11507009 | ||
| Pubmed | The structure of the Na+,K+-ATPase and mapping of isoform differences and disease-related mutations. | 9.73e-06 | 2 | 109 | 2 | 18957371 | |
| Pubmed | All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. | 9.73e-06 | 2 | 109 | 2 | 11546672 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24391932 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26201020 | ||
| Pubmed | Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone. | 9.73e-06 | 2 | 109 | 2 | 33849267 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22157716 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21061259 | ||
| Pubmed | Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons. | 9.73e-06 | 2 | 109 | 2 | 23761886 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 27472040 | ||
| Pubmed | A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17. | 9.73e-06 | 2 | 109 | 2 | 34416436 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10448096 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12077118 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15983030 | ||
| Pubmed | Ion pumps in polarized cells: sorting and regulation of the Na+, K+- and H+, K+-ATPases. | 9.73e-06 | 2 | 109 | 2 | 11404365 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20952666 | ||
| Pubmed | The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit. | 9.73e-06 | 2 | 109 | 2 | 3030810 | |
| Pubmed | Expression of alpha isoforms of the Na,K-ATPase in human heart. | 9.73e-06 | 2 | 109 | 2 | 8391840 | |
| Pubmed | Molecular cloning of complementary DNA encoding one of the human pancreatic protease E isozymes. | 9.73e-06 | 2 | 109 | 2 | 2460440 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21498719 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18795391 | ||
| Pubmed | Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase. | 9.73e-06 | 2 | 109 | 2 | 19376809 | |
| Pubmed | ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. | 9.73e-06 | 2 | 109 | 2 | 18650320 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 35446892 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 14742675 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 9407109 | ||
| Pubmed | ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. | 9.73e-06 | 2 | 109 | 2 | 33880529 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10555956 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 30528300 | ||
| Pubmed | DOCA-salt hypertension does not require the ouabain-sensitive binding site of the α2 Na,K-ATPase. | 9.73e-06 | 2 | 109 | 2 | 22258333 | |
| Pubmed | Expression of thyroid hormone transporters in the human hypothalamus. | 9.73e-06 | 2 | 109 | 2 | 21508134 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22739122 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10360172 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23356447 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15700541 | ||
| Pubmed | Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load. | 9.73e-06 | 2 | 109 | 2 | 18667729 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21632957 | ||
| Pubmed | ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons. | 9.73e-06 | 2 | 109 | 2 | 31564162 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24356962 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19759332 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 2826474 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 30171605 | ||
| Pubmed | ACSL6 VWF NRCAM FAM98B GRM1 MYEF2 SLC12A5 NF1 SPON1 UGP2 USP7 ATP1A1 ATP1A2 ATP1A3 ATP2B1 SYNCRIP | 1.00e-05 | 1431 | 109 | 16 | 37142655 | |
| Pubmed | 1.06e-05 | 14 | 109 | 3 | 1572638 | ||
| Pubmed | 1.33e-05 | 15 | 109 | 3 | 17010969 | ||
| Pubmed | 1.97e-05 | 17 | 109 | 3 | 36230906 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEMA3C MANBA HLA-B ITGB8 IGSF10 MGAT5 NF1 PSMG1 ADAM17 ATP1A1 EXOSC7 ATP2B1 SLC27A3 CREB3L2 | 2.40e-05 | 1201 | 109 | 14 | 35696571 |
| Pubmed | 2.80e-05 | 19 | 109 | 3 | 20861386 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 11557593 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 34414454 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 34669927 | ||
| Pubmed | In situ localization of sodium-potassium ATPase mRNA in developing mouse lung epithelium. | 2.91e-05 | 3 | 109 | 2 | 7573462 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 35203278 | ||
| Pubmed | Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription. | 2.91e-05 | 3 | 109 | 2 | 23267096 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 37046278 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 35063769 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18430733 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 9159180 | ||
| Pubmed | LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. | 2.91e-05 | 3 | 109 | 2 | 27166870 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 15383549 | ||
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.23e-08 | 7 | 80 | 4 | 1208 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 1.15e-04 | 4 | 80 | 2 | 1044 | |
| GeneFamily | Acyl-CoA synthetase family | 2.02e-04 | 26 | 80 | 3 | 40 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.39e-04 | 161 | 80 | 5 | 593 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.15e-03 | 19 | 80 | 2 | 50 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK NRCAM DYNC2H1 ZEB2 ADAMTS12 IGSF10 SPON1 ADAMTS15 PRKG1 | 1.45e-09 | 199 | 108 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.51e-09 | 200 | 108 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-08 | 194 | 108 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.62e-08 | 195 | 108 | 8 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-08 | 199 | 108 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.19e-08 | 200 | 108 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.19e-08 | 200 | 108 | 8 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 3.19e-08 | 200 | 108 | 8 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-07 | 191 | 108 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-07 | 192 | 108 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-07 | 192 | 108 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-07 | 192 | 108 | 7 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-07 | 192 | 108 | 7 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-07 | 192 | 108 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-07 | 193 | 108 | 7 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.64e-07 | 193 | 108 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-07 | 193 | 108 | 7 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-07 | 193 | 108 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-07 | 195 | 108 | 7 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-07 | 195 | 108 | 7 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-07 | 198 | 108 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Epithelial-Epithelial-D_(Clara-Club_cells)|Epithelial / shred on cell class and cell subclass (v4) | 5.63e-07 | 123 | 108 | 6 | caa1576f1b5eb592d522be61c090ac444e277ac5 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.70e-07 | 199 | 108 | 7 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.01e-06 | 164 | 108 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-06 | 168 | 108 | 6 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-06 | 168 | 108 | 6 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-06 | 169 | 108 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-06 | 169 | 108 | 6 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.71e-06 | 170 | 108 | 6 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-06 | 176 | 108 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-06 | 176 | 108 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.67e-06 | 177 | 108 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.83e-06 | 178 | 108 | 6 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 179 | 108 | 6 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.31e-06 | 181 | 108 | 6 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.31e-06 | 181 | 108 | 6 | cb17c904ab86d56dd30cac9b61acbb3b76f84ded | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.31e-06 | 181 | 108 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-06 | 182 | 108 | 6 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-06 | 182 | 108 | 6 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.66e-06 | 183 | 108 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 5.84e-06 | 184 | 108 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 6.02e-06 | 185 | 108 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.02e-06 | 185 | 108 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.21e-06 | 186 | 108 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.60e-06 | 188 | 108 | 6 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 189 | 108 | 6 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.81e-06 | 189 | 108 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 6.81e-06 | 189 | 108 | 6 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 189 | 108 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 189 | 108 | 6 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 7.01e-06 | 190 | 108 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-06 | 190 | 108 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-06 | 190 | 108 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-06 | 190 | 108 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.23e-06 | 191 | 108 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-06 | 191 | 108 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.23e-06 | 191 | 108 | 6 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 191 | 108 | 6 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.23e-06 | 191 | 108 | 6 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-06 | 191 | 108 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-06 | 191 | 108 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.23e-06 | 191 | 108 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.45e-06 | 192 | 108 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.45e-06 | 192 | 108 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.45e-06 | 192 | 108 | 6 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.45e-06 | 192 | 108 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.45e-06 | 192 | 108 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.67e-06 | 193 | 108 | 6 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.67e-06 | 193 | 108 | 6 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-06 | 193 | 108 | 6 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.67e-06 | 193 | 108 | 6 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.67e-06 | 193 | 108 | 6 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.67e-06 | 193 | 108 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-06 | 193 | 108 | 6 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-06 | 193 | 108 | 6 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.90e-06 | 194 | 108 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.90e-06 | 194 | 108 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.90e-06 | 194 | 108 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.90e-06 | 194 | 108 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.90e-06 | 194 | 108 | 6 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-06 | 195 | 108 | 6 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-06 | 195 | 108 | 6 | c51b1bee79e77aa2ac444a4883ef533c0095eaad | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.14e-06 | 195 | 108 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.38e-06 | 196 | 108 | 6 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.38e-06 | 196 | 108 | 6 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; PC3; HT_HG-U133A | 4.08e-07 | 198 | 107 | 9 | 4258_UP | |
| Drug | 22,23-dihydrobufalin | 1.00e-06 | 5 | 107 | 3 | CID000195392 | |
| Drug | thevetin A | 1.00e-06 | 5 | 107 | 3 | CID000441873 | |
| Drug | 3-acetylstrophanthin | 1.00e-06 | 5 | 107 | 3 | CID003082282 | |
| Drug | ETH157 | 2.00e-06 | 6 | 107 | 3 | CID000563154 | |
| Drug | dihydrodigitoxigenin | 3.48e-06 | 7 | 107 | 3 | CID000107549 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A | 4.27e-06 | 197 | 107 | 8 | 2703_UP | |
| Drug | C070379 | 4.60e-06 | 199 | 107 | 8 | CID003034747 | |
| Drug | ouabagenin | 1.62e-05 | 11 | 107 | 3 | CID000010497 | |
| Drug | Digocin | 1.98e-05 | 70 | 107 | 5 | CID000003062 | |
| Drug | vitamin D2 | 2.03e-05 | 244 | 107 | 8 | CID000003249 | |
| Drug | chloride | MANBA GRM1 SLC12A5 ACE2 DMC1 GMCL1 GMCL2 PTGR1 NFKB1 DDX25 PRKG1 ATP1A1 ATP1A2 ATP1A3 EXOSC7 SLC16A10 | 2.45e-05 | 1029 | 107 | 16 | CID000000312 |
| Drug | A-32686 | 2.79e-05 | 13 | 107 | 3 | CID000004951 | |
| Drug | Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 7524_UP | |
| Drug | TBHQ | 5.48e-05 | 141 | 107 | 6 | CID000016043 | |
| Drug | Digoxin | 6.46e-05 | 46 | 107 | 4 | ctd:D004077 | |
| Drug | HDMA | 6.54e-05 | 17 | 107 | 3 | CID000131092 | |
| Drug | Ammonia | 7.65e-05 | 48 | 107 | 4 | ctd:D000641 | |
| Drug | Fenoprofen | 7.82e-05 | 18 | 107 | 3 | ctd:D005279 | |
| Drug | AC1L1F3Q | 7.82e-05 | 18 | 107 | 3 | CID000003068 | |
| Drug | acetylstrophanthidin | 7.82e-05 | 18 | 107 | 3 | CID000006062 | |
| Drug | NSC 234205 | 7.82e-05 | 18 | 107 | 3 | CID000010104 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 5.89e-09 | 7 | 108 | 4 | DOID:0060178 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 8.21e-08 | 12 | 108 | 4 | DOID:863 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.41e-06 | 163 | 108 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | allergic rhinitis | 9.83e-06 | 133 | 108 | 6 | EFO_0005854 | |
| Disease | ALTERNATING HEMIPLEGIA OF CHILDHOOD 1 | 1.33e-05 | 2 | 108 | 2 | C3549447 | |
| Disease | alternating hemiplegia of childhood (is_implicated_in) | 1.33e-05 | 2 | 108 | 2 | DOID:0050635 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | EYA4 SALL3 NRCAM OBSCN GRM1 ZEB2 SLC12A5 GMCL2 NF1 ABCA5 ADAMTS15 | 5.45e-05 | 702 | 108 | 11 | C0009402 |
| Disease | Alternating hemiplegia of childhood | 7.93e-05 | 4 | 108 | 2 | C0338488 | |
| Disease | allergic disease, age at onset | 1.37e-04 | 71 | 108 | 4 | EFO_0004847, MONDO_0005271 | |
| Disease | Eczema, allergic rhinitis | 1.44e-04 | 215 | 108 | 6 | EFO_0005854, HP_0000964 | |
| Disease | skin pigmentation measurement | 1.52e-04 | 137 | 108 | 5 | EFO_0007009 | |
| Disease | waist-hip ratio | SEMA3C EYA4 DYNC2H1 DNAJC27 EYA2 ITGB8 MEFV CFAP65 CELF1 ADAM17 DLEC1 CLEC16A PHLDB2 KNL1 | 1.55e-04 | 1226 | 108 | 14 | EFO_0004343 |
| Disease | eye disease (implicated_via_orthology) | 1.97e-04 | 6 | 108 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | oxalate measurement | 2.19e-04 | 32 | 108 | 3 | EFO_0010517 | |
| Disease | seasonal allergic rhinitis | 2.19e-04 | 32 | 108 | 3 | EFO_0003956 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.61e-04 | 84 | 108 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | Vasodilators used in cardiac diseases use measurement | 2.63e-04 | 34 | 108 | 3 | EFO_0009926 | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 2.75e-04 | 7 | 108 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome (is_implicated_in) | 2.75e-04 | 7 | 108 | 2 | DOID:2945 (is_implicated_in) | |
| Disease | Adenoma, Microcystic | 3.12e-04 | 36 | 108 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 3.12e-04 | 36 | 108 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 3.12e-04 | 36 | 108 | 3 | C0205646 | |
| Disease | Follicular adenoma | 3.12e-04 | 36 | 108 | 3 | C0205647 | |
| Disease | Papillary adenoma | 3.12e-04 | 36 | 108 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 3.12e-04 | 36 | 108 | 3 | C0205651 | |
| Disease | Adenoma | 3.12e-04 | 36 | 108 | 3 | C0001430 | |
| Disease | allergic disease | 3.83e-04 | 258 | 108 | 6 | MONDO_0005271 | |
| Disease | cups of coffee per day measurement | 4.27e-04 | 40 | 108 | 3 | EFO_0006782 | |
| Disease | atrial fibrillation | 4.41e-04 | 371 | 108 | 7 | EFO_0000275 | |
| Disease | hepatocyte growth factor measurement | 5.66e-04 | 44 | 108 | 3 | EFO_0006903 | |
| Disease | biliary liver cirrhosis | 5.66e-04 | 44 | 108 | 3 | EFO_0004267 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.86e-04 | 10 | 108 | 2 | cv:C4707243 | |
| Disease | myelodysplastic syndrome | 5.86e-04 | 10 | 108 | 2 | EFO_0000198 | |
| Disease | Hypertensive disease | 6.85e-04 | 190 | 108 | 5 | C0020538 | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 7.14e-04 | 11 | 108 | 2 | DOID:14004 (is_implicated_in) | |
| Disease | testosterone measurement | MANBA CAMP RNASE12 NCOR2 MGAT5 NF1 NFKB1 USP7 UGT2B7 ATP1A3 USH2A NR1D2 KNL1 | 7.86e-04 | 1275 | 108 | 13 | EFO_0004908 |
| Disease | hyperhomocysteinemia (biomarker_via_orthology) | 8.55e-04 | 12 | 108 | 2 | DOID:9279 (biomarker_via_orthology) | |
| Disease | trait in response to apixaban | 8.59e-04 | 115 | 108 | 4 | OBA_2050328 | |
| Disease | lymphocyte measurement | 9.16e-04 | 117 | 108 | 4 | EFO_0803546 | |
| Disease | adult onset asthma | 9.45e-04 | 118 | 108 | 4 | EFO_1002011 | |
| Disease | abdominal adipose tissue measurement | 9.78e-04 | 53 | 108 | 3 | EFO_0803316 | |
| Disease | childhood onset asthma | 1.46e-03 | 334 | 108 | 6 | MONDO_0005405 | |
| Disease | primary biliary cirrhosis | 1.47e-03 | 133 | 108 | 4 | EFO_1001486 | |
| Disease | hypertension (biomarker_via_orthology) | 1.51e-03 | 227 | 108 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | theta wave measurement | 1.74e-03 | 17 | 108 | 2 | EFO_0006873 | |
| Disease | Moyamoya Disease | 1.74e-03 | 17 | 108 | 2 | C0026654 | |
| Disease | asthma | 1.78e-03 | 751 | 108 | 9 | MONDO_0004979 | |
| Disease | sclerosing cholangitis | 1.85e-03 | 66 | 108 | 3 | EFO_0004268 | |
| Disease | vital capacity | EYA4 RARG DNAJC27 EYA2 ITGB8 CELA3B NCOR2 CELF1 ADAMTS15 PRKG1 FAM162A PDZD2 | 1.90e-03 | 1236 | 108 | 12 | EFO_0004312 |
| Disease | alcohol consumption measurement | KIRREL3-AS3 HLA-B DMC1 NCOR2 NF1 CELF1 ATP1A3 RIMS2 DNAH5 CLEC16A NR1D2 SLC16A10 | 1.98e-03 | 1242 | 108 | 12 | EFO_0007878 |
| Disease | rosacea severity measurement | 2.12e-03 | 147 | 108 | 4 | EFO_0009180 | |
| Disease | Malignant Glioma | 2.18e-03 | 70 | 108 | 3 | C0555198 | |
| Disease | mixed gliomas | 2.18e-03 | 70 | 108 | 3 | C0259783 | |
| Disease | coagulation factor measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0004634 | |
| Disease | alpha-tocopherol measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0007898 | |
| Disease | susceptibility to mumps measurement | 2.66e-03 | 75 | 108 | 3 | EFO_0008404 | |
| Disease | COVID-19 (is_implicated_in) | 2.66e-03 | 21 | 108 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | asthma (is_implicated_in) | 2.69e-03 | 157 | 108 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | otitis media (implicated_via_orthology) | 2.92e-03 | 22 | 108 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | small cell lung carcinoma | 3.19e-03 | 80 | 108 | 3 | EFO_0000702 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 3.19e-03 | 23 | 108 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 3.19e-03 | 23 | 108 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 3.19e-03 | 23 | 108 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 3.19e-03 | 23 | 108 | 2 | C0014556 | |
| Disease | susceptibility to shingles measurement | 3.31e-03 | 81 | 108 | 3 | EFO_0008401 | |
| Disease | Behcet Syndrome | 3.48e-03 | 24 | 108 | 2 | C0004943 | |
| Disease | high density lipoprotein particle size measurement | 3.58e-03 | 170 | 108 | 4 | EFO_0008592 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DRKAVISQGMLKCVG | 681 | Q8WWZ7 | |
| IRKGCIKTISGRMTF | 206 | Q6ZUV0 | |
| FIGMISKKCTENDIR | 111 | Q92879 | |
| TMNEQGFCKIVGRSK | 496 | Q96CM8 | |
| KSVGICTIKGIQMTT | 41 | Q14565 | |
| LQTGRVVEQMGKFCV | 181 | Q9UHL0 | |
| KCQRAGITVRMVTGD | 696 | P20020 | |
| CQTVRKMFKQKEGSG | 701 | P58397 | |
| TGKAKGQMVCQTRHF | 471 | Q8TE58 | |
| GETMKETVNVKTVCG | 201 | Q96IK5 | |
| KINCGSGRVTPIKIM | 916 | Q8IXT5 | |
| RLQKCFEVGMSKEAV | 146 | P13631 | |
| FLRSGTKRVMCKVLG | 196 | Q8N7Y1 | |
| AIARMVGSKTVSQCK | 636 | Q9Y618 | |
| VVKEGQMGRFSCKIT | 171 | Q15746 | |
| KASECMQVIFGIDVK | 156 | P43361 | |
| EIMKKVVGNRSGCPT | 326 | Q09328 | |
| VVQRGSMVSFECKVK | 556 | Q92823 | |
| KKSGGMKIVCQSEVR | 1111 | Q38SD2 | |
| SMGNAEVGKSCIIKR | 21 | Q9NZQ0 | |
| GKVEVTKEGVKLCTM | 146 | Q13976 | |
| RRSIQTGTKQFGMCV | 596 | Q17RB8 | |
| FQRTKEHCLMGIKGT | 281 | Q9HCE5 | |
| MFTLTGCRLVEKTQK | 1 | Q6ZU64 | |
| DAVGKCRSAGIKVIM | 601 | P05023 | |
| CGVMKTYRQREKQGT | 96 | O60506 | |
| KNSEVKGALTRCMGR | 291 | A6NH00 | |
| TTGVTCSKAIKIFMG | 911 | Q02817 | |
| DCIRGQMGIFVKTIF | 606 | O15018 | |
| SIQSSPKCIVGKFRM | 146 | P00488 | |
| TTMNRQIAVKVEKCG | 821 | Q8NG31 | |
| GGVKLFQEMCDKVQI | 196 | Q86UY5 | |
| ILGACKTSISRKGNM | 666 | O15553 | |
| TSKGVVTCMRKVGKG | 231 | Q15024 | |
| VVAAVMCRRKSSGGK | 326 | P01889 | |
| KLSFSSKVRMEAVGC | 1481 | Q5VST9 | |
| LKVVGGKMTESGRLC | 681 | Q9UQ26 | |
| GKMTESGRLCAFITK | 686 | Q9UQ26 | |
| EKVFGSCPRKNMQIT | 151 | O95456 | |
| NVTVTMKKCDVTGGK | 431 | P26012 | |
| VKSMGRIFVGLVKCG | 1721 | Q8NCM8 | |
| GKCRSAGIKVIMVTG | 601 | P50993 | |
| ATKIGKESCFERIMQ | 576 | O95677 | |
| MKVKGRGITCLLVSF | 1 | Q6WRI0 | |
| TMFKLGKDITLQCRG | 1171 | Q8N6C5 | |
| GYTMNVEIKCKDRTG | 4186 | Q4G0P3 | |
| STVKKTMVCAGGYIR | 196 | P09093 | |
| VGTCRGRQMEIQKHK | 21 | Q8IU53 | |
| MSCGNEFVETLKKIG | 1 | Q68CZ6 | |
| LGKGDFRILMCTKVT | 351 | Q9BYF1 | |
| SSVKKTMVCAGGDIR | 196 | P08861 | |
| EKTACAINKVLMGRV | 291 | Q52LJ0 | |
| LMEKEINGSKVTCRG | 306 | Q6DD88 | |
| KDGLVKRCMGTVTLN | 101 | P49913 | |
| VCSRVTERFVMKGGE | 731 | O00462 | |
| DAVGKCRSAGIKVIM | 591 | P13637 | |
| IQKAISGFRKCAMIS | 951 | Q92538 | |
| NVMSSKRVGICKGAT | 1111 | Q05BV3 | |
| KIQMNKSGVVRSVCS | 511 | Q13255 | |
| GGVKMTRFICKNVGF | 491 | Q9Y238 | |
| EMKCTLGSKVGYQVR | 121 | Q8IX18 | |
| TKFKMTVCQLIEGTR | 101 | Q5GAN4 | |
| CGRAFTTKGNLKVHM | 1146 | Q9BXA9 | |
| VMGKVSRTCKLAGTQ | 361 | Q70SY1 | |
| VMVITCFIFKKTVGD | 311 | Q6ZN68 | |
| IKKEVVQCMGSFQDG | 3141 | Q8TE73 | |
| SSKDRGKMVSLFCGI | 266 | Q9GZK3 | |
| VSKKNIISNVGCMTR | 86 | Q96RD0 | |
| VIGQMKKFGRIAICG | 226 | Q14914 | |
| MEAEKVKGFCQVVIS | 756 | Q9H2X9 | |
| SGVTKFSGMVLLCKV | 91 | Q14995 | |
| TKTGKESCFERIMQR | 476 | O00167 | |
| GCMKDVKFTRGAVVN | 1861 | O75445 | |
| NKSCGKGHVIRTRMI | 681 | Q9HCB6 | |
| QVFMIDSKCESGKGR | 151 | Q99985 | |
| EKACRIMNGIKISGR | 576 | Q9P2K5 | |
| MQCGLVGKIIKRFEQ | 1 | O60361 | |
| GETMKETINVKTVCG | 201 | Q8NEA9 | |
| RQKFLVTMKGETVCT | 56 | A6NM43 | |
| RQKFLVTMKGETVCT | 56 | Q96SF2 | |
| CGGKQVEITLERTKM | 51 | Q9BXB7 | |
| LKGKITVQFSDMRTC | 951 | Q9BVR0 | |
| ITEKTCRGFLIKMGG | 1141 | Q86SQ0 | |
| TMGLKATGRLCTVAK | 156 | Q8N6T7 | |
| TVVGCIFMVIEGKKA | 111 | Q96A26 | |
| TVGFCDMNGKCEKRV | 631 | P78536 | |
| ERGQKCGVVIKSMQA | 236 | Q9UKU0 | |
| KCRSAGIKVIMVTGD | 611 | Q13733 | |
| KGKRCSLVFGLIIMT | 76 | Q7LFX5 | |
| IACTVITKDGGMVQR | 711 | Q2KHT3 | |
| PNGKRCEFVMEVTNK | 271 | Q16851 | |
| KECGKGFIQRSSLLM | 401 | O14709 | |
| MVQVGVISGFKLECR | 2606 | P04275 | |
| AECGRGVSMFRTKKT | 466 | Q0IIM8 | |
| GCMGIGATVVLKSKF | 341 | Q5K4L6 | |
| FTRKKCTIGMVGEGS | 111 | Q9NX95 | |
| LGVKESAMVNKIFTC | 181 | P30825 | |
| VEKMFGGKIVTRICC | 566 | Q9P2H5 | |
| GIVMKKFRISVCGAA | 411 | Q9NYB5 | |
| NMIGLVRKFVDSICK | 221 | Q86UB9 | |
| GIKLCKAMSLGSVTF | 11 | Q6ECI4 | |
| GNVKLVSSKVIGRMC | 2041 | P21359 | |
| KVNNEGCFIKVMTII | 191 | O43657 | |
| SCMVGVARDSVKRKG | 436 | Q12899 | |
| TGVFQVAEKMEKRTC | 31 | Q9UIL8 | |
| VSFRFCVVMGKQQSK | 16 | Q8NA23 | |
| MSIFGDITRKFCKDV | 116 | P16662 | |
| SKKCIGLISVNGRMR | 331 | O60315 | |
| NVENKMKGTCVEGTI | 306 | Q93009 | |
| KNKEVVLMCIGVTSG | 326 | Q8TF71 | |
| KIVRMDRTAGCVTGG | 251 | P19838 |